ATNXEUR
Athenex, Inc.
A biopharmaceutical company that made therapies for cancer, including oral chemotherapy built on its Orascovery platform and cell-based cancer treatments. It began in 2003 as a spinoff of the University at Buffalo, launched by medicinal chemist David Hangauer, who turned to cancer research after family members struggled with the disease. Originally named Kinex Pharmaceuticals, the firm renamed itself Athenex in 2015 to reflect its broader global ambitions.
CUSIP: 04685N103HealthcareUS1 holder
Total Value
$254.0K
Total Shares
20.0K
Net Share Change
+20.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
